Cyclophosphamide as an adjuvant to X-rays in treatment of a radioresistant solid tumor of the rat, hepatoma H-4-II-E
- PMID: 536257
- DOI: 10.1016/0360-3016(79)90751-x
Cyclophosphamide as an adjuvant to X-rays in treatment of a radioresistant solid tumor of the rat, hepatoma H-4-II-E
Similar articles
-
The effect of varying the time between irradiation and cyclophosphamide on growth response of hepatoma 3924A.Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1455-9. doi: 10.1016/0360-3016(79)90748-x. Int J Radiat Oncol Biol Phys. 1979. PMID: 536255 No abstract available.
-
Solid tumor models for the assessment of different treatment modalities--XIV: the evaluation of host and tumor response to cyclophosphamide and radiation.Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1461-5. doi: 10.1016/0360-3016(79)90749-1. Int J Radiat Oncol Biol Phys. 1979. PMID: 536256 No abstract available.
-
Combination therapy of a solid murine tumor with cyclophosphamide and radiation: the effects of time, dose and assay method.Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1433-9. doi: 10.1016/0360-3016(79)90744-2. Int J Radiat Oncol Biol Phys. 1979. PMID: 536253 No abstract available.
-
Alternation of chemotherapy and radiotherapy in cancer management. III. Results in experimental solid tumor systems and their relationship to clinical studies.Cancer Treat Rep. 1986 Jan;70(1):141-62. Cancer Treat Rep. 1986. PMID: 3002620 Review. No abstract available.
-
Hyperthermic potentiation: biological aspects and applications to radiation therapy.Cancer. 1977 Feb;39(2 Suppl):766-79. doi: 10.1002/1097-0142(197702)39:2+<766::aid-cncr2820390711>3.0.co;2-5. Cancer. 1977. PMID: 319897 Review.
Cited by
-
The time-pattern of rises and falls in proliferation fades with senescence of mortal lines and is perpetuated in immortal rat hepatoma Fao cell line.In Vitro Cell Dev Biol Anim. 1998 Feb;34(2):163-9. doi: 10.1007/s11626-998-0100-3. In Vitro Cell Dev Biol Anim. 1998. PMID: 9542655
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources